title: Systematic Review of Pharmacological Properties of the Oligodendrocyte Lineage.
abstract: Oligodendrogenesis and oligodendrocyte precursor maturation are essential processes during the course of central nervous system development, and lead to the myelination of axons. Cells of the oligodendrocyte lineage are generated in the germinal zone from migratory bipolar oligodendrocyte precursor cells (OPCs), and acquire cell surface markers as they mature and respond specifically to factors which regulate proliferation, migration, differentiation, and survival. Loss of myelin underlies a wide range of neurological disorders, some of an autoimmune nature-multiple sclerosis probably being the most prominent. Current therapies are based on the use of immunomodulatory agents which are likely to promote myelin repair (remyelination) indirectly by subverting the inflammatory response, aspects of which impair the differentiation of OPCs. Cells of the oligodendrocyte lineage express and are capable of responding to a diverse array of ligand-receptor pairs, including neurotransmitters and nuclear receptors such as γ-aminobutyric acid, glutamate, adenosine triphosphate, serotonin, acetylcholine, nitric oxide, opioids, prostaglandins, prolactin, and cannabinoids. The intent of this review is to provide the reader with a synopsis of our present state of knowledge concerning the pharmacological properties of the oligodendrocyte lineage, with particular attention to these receptor-ligand (i.e., neurotransmitters and nuclear receptor) interactions that can influence oligodendrocyte migration, proliferation, differentiation, and myelination, and an appraisal of their therapeutic potential. For example, many promising mediators work through Ca(2+) signaling, and the balance between Ca(2+) influx and efflux can determine the temporal and spatial properties of oligodendrocytes (OLs). Moreover, Ca(2+) signaling in OPCs can influence not only differentiation and myelination, but also process extension and migration, as well as cell death in mature mouse OLs. There is also evidence that oligodendroglia exhibit Ca(2+) transients in response to electrical activity of axons for activity-dependent myelination. Cholinergic antagonists, as well as endocannabinoid-related lipid-signaling molecules target OLs. An understanding of such pharmacological pathways may thus lay the foundation to allow its leverage for therapeutic benefit in diseases of demyelination.
authors.affiliation: Department of Pharmaceutical and Pharmacological Sciences, University of Padua Padua, Italy.
authors.forename: Carla
authors.initials: C
authors.lastname: Marinelli
authors.affiliation: Department of Pharmaceutical and Pharmacological Sciences, University of Padua Padua, Italy.
authors.forename: Thomas
authors.initials: T
authors.lastname: Bertalot
authors.affiliation: Department of Pharmaceutical and Pharmacological Sciences, University of Padua Padua, Italy.
authors.forename: Morena
authors.initials: M
authors.lastname: Zusso
authors.affiliation: Department of Pharmaceutical and Pharmacological Sciences, University of Padua Padua, Italy.
authors.forename: Stephen D
authors.initials: SD
authors.lastname: Skaper
authors.affiliation: Department of Pharmaceutical and Pharmacological Sciences, University of Padua Padua, Italy.
authors.forename: Pietro
authors.initials: P
authors.lastname: Giusti
keywords: GABA; cholinergic; glutamatergic; muscarinergic; nuclear receptor; oligodendrocyte; opioids; regeneration